Web Results

Pf prism cv drug patent status and generic equivalents

www.drugpatentwatch.com/p/applicant/Pf Prism Cv

Pf prism cv drug patent expiration information and generic drug list.

Subsidiaries of the Company

www.sec.gov/Archives/edgar/data/78003/000119312512085703/d278590dex21.htm

PF Asia Manufacturing Coöperatief U.A.. Netherlands. PF PR Holdings C.V.. Netherlands. PF PRISM C.V.. Netherlands. PF PRISM Holdings S.a.r.l.. Luxembourg.

Pfizer, Wyeth and PF Prism file suit against Watson over generic Pristiq

www.news-medical.net/news/20120626/Pfizer-Wyeth-and-PF-Prism-file-suit-against-Watson-over-generic-Pristiq.aspx

Jun 26, 2012 ... Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and PF Prism C.V. filed suit against Watson on June 22, 2012 in the United States District ...

Product Details for NDA 021446 - Orange Book: Approved Drug ...

www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021446

Product Number: 001. Approval Date: Dec 30, 2004. Applicant Holder Full Name: PF PRISM CV Marketing Status: Prescription Patent and Exclusivity Information ...

in the united states district court for the district of delaware pfizer inc ...

www.ded.uscourts.gov/sites/default/files/opinions/gms/2014/october/10-528.pdf

Pharmaceuticals LLC, and PF Prism C.V. (collectively, "Pfizer") allege that ... Plaintiff C.P. Pharmaceuticals International C.V. ("CPPI CV") is a limited partnership.

Generic Rapamune Availability - Drugs.com

www.drugs.com/availability/generic-rapamune.html

RAPAMUNE (sirolimus - solution;oral). Manufacturer: PF PRISM CV Approval date: September 15, 1999. Strength(s): 1MG/ML ...

Generic Xalkori Availability - Drugs.com

www.drugs.com/availability/generic-xalkori.html

XALKORI (crizotinib - capsule;oral). Manufacturer: PF PRISM CV Approval date: August 26, 2011. Strength(s): 200MG, 250MG ...

Generic Vfend Availability - Drugs.com

www.drugs.com/availability/generic-vfend.html

VFEND (voriconazole - for suspension;oral). Manufacturer: PF PRISM CV Approval date: December 19, 2003. Strength(s): 200MG/5ML ...

Generic Zmax Availability - Drugs.com

www.drugs.com/availability/generic-zmax.html

ZMAX (azithromycin - for suspension, extended release;oral). Manufacturer: PF PRISM CV Approval date: June 10, 2005. Strength(s): EQ 2GM BASE/BOT ...

Login | XELJANZ

www.xeljanz.ca/

member of eXel. XELJANZ ® PF Prism C.V., owner/Pfizer Canada Inc., Licensee © 2016 Pfizer Canada Inc., Kirkland, Quebec H9J 2M5. EXEL TM Pfizer Inc.,

More Info

PHARMACEUTICALS LLC, PF PRISM ) C.V., and PFIZER ...

search.rpxcorp.com

Sep 25, 2013 ... wholly-owned subsidiary of PF PRISM C.V.. 5. Plaintiff PF PRISM C.V. is a limited partnership (commanditaire vennootschap) organized and ...

here - Patent Docs

patentdocs.typepad.com

Aug 8, 2014 ... Plaintiffs Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and PF Prism C.V.. ( collectively, “Plaintiffs”), by their undersigned attorneys, ...

Xeljanz - FDA

www.fda.gov

REMS. Initial REMS Approval: 11/06/2012. Most Recent Modification: 6/2015. NDA 203,214 XELJANZ. ®. (TOFACITINIB). PF PRISM C.V. c/o Pfizer Netherlands, ...